Harrisson S et al. Six month interim results of MSDC-0602K in a large phase 2b NASH study demonstrate significant improvement in liver enzymes and glycemic control (NCT02784444). (Abstract PS-111)
Tafenoquine bij ‘Plasmodium vivax’-malaria
apr 2019 | Parasitaire infecties